Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/09/2013 | CN102438625B Pharmaceutical composition for neuroprotective treatment in patients with ictus comprising citicoline and uric acid |
10/09/2013 | CN102430082B Traditional Chinese medicine sachet and preparation method thereof |
10/09/2013 | CN102379857B Levetiracetam slow release medicinal composition and preparation method thereof |
10/09/2013 | CN102366406B Salmeterol/fluticasone aerosol preparation with hydrofluoroalkane as propellent |
10/09/2013 | CN102325524B Process to make fusidic acid cream |
10/09/2013 | CN102295635B Antitumor medicament tetralin amide compounds and pharmaceutically acceptable salts thereof as well as preparation method and application of antitumor medicament tetralin amide compounds |
10/09/2013 | CN102292068B Transdermal delivery of diclofenac, carbamazepine and benzydamine |
10/09/2013 | CN102276444B Fatty acid compounds and preparation method and application thereof |
10/09/2013 | CN102274206B Application of germacrone in preparation of medicament for treating or preventing influenza viruses |
10/09/2013 | CN102266569B Application of miR-199a and inhibitor thereof |
10/09/2013 | CN102247377B Application of carbon drop quinone methyl triterpene in preparation of drug for preventing and treating diabetes |
10/09/2013 | CN102219725B Benzohetercyclic compound as well as preparation method and applications thereof |
10/09/2013 | CN102218145B Medicinal composition for protecting optic nerve of glaucoma and preparation method thereof |
10/09/2013 | CN102210693B Method for preparing aspirin and dipyridamole multilayer tablets |
10/09/2013 | CN102204917B Pharmaceutical composition containing fasudil and sildenafil, and preparation method and application thereof |
10/09/2013 | CN102198264B Beta-defensin 15 of specific antibacterial peptides of rat epididymis and application thereof |
10/09/2013 | CN102083809B Immunosuppressor based on the interruption of TCR-Nck interaction |
10/09/2013 | CN101917973B Process for recovering flunixin from pharmaceutical compositions |
10/09/2013 | CN101821254B Adrenergic compounds |
10/09/2013 | CN101801954B Compounds and compositions as modulators of GPR119 activity |
10/09/2013 | CN101659649B Novel epigallocatechin gallate tetramer, and vascular endothelial function improver comprising same |
10/09/2013 | CN101584746B Medicine composition for healing wounds and preparation method thereof |
10/09/2013 | CN101374807B Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
10/09/2013 | CN101237874B A carbohydrate fraction and use thereof for a flat postprandial glucose response |
10/08/2013 | US8552206 NF-κB inhibitors and uses thereof |
10/08/2013 | US8552205 Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amides |
10/08/2013 | US8552202 Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitors |
10/08/2013 | US8552201 5, 6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin II receptor antagonists |
10/08/2013 | US8552200 Substituted 6-amino-nicotinamides as KCNQ2/3 modulators |
10/08/2013 | US8552199 Substituted indanes, method for the production thereof, and use thereof as drugs |
10/08/2013 | US8552198 Benzimidazole compound crystal |
10/08/2013 | US8552197 Sorafenib ethylsulfonate salt, process for preparation and use |
10/08/2013 | US8552196 Apoptosis signal-regulating kinase inhibitors |
10/08/2013 | US8552193 Alternative forms of the phosphodiesterase-4 inhibitor N-cyclopropyl-1-{3-[(1-oxidopryidin-3-yl)ethynyl]phenyl}-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxyamide |
10/08/2013 | US8552184 Compounds and methods for treating disorders related to glucose metabolism |
10/08/2013 | US8552177 Room temperature stable agarose solutions |
10/08/2013 | US8552171 RNA sequence-specific mediators of RNA interference |
10/08/2013 | US8552135 Substituted polyalkoxysiloxane compositions and methods of use |
10/08/2013 | US8552069 Method for treatment of obesity, dyslipidemia, fatty liver or insulin resistance syndrome comprising camphene as active ingredient |
10/08/2013 | US8552068 Compositions and methods |
10/08/2013 | US8552067 poly(imino-keto-methylene/amine) derivatives as a bioactive part in conjugates; diarrhea caused by pathogens: Vibrio cholerae, Clostridium difficile, Escherichia coli, Shigella, Salmonella, rotavirus; or enterotoxins: cholera toxin, E. coli toxin, Salmonella toxin |
10/08/2013 | US8552066 Modified chalcone compounds as antimitotic agents |
10/08/2013 | US8552065 Biarylamide derivative and compositions containing the derivative as an active ingredient |
10/08/2013 | US8552064 Suramin and derivatives thereof as topical microbicide and contraceptive |
10/08/2013 | US8552063 Composition for accelerated production of collagen |
10/08/2013 | US8552062 Methods for the treatment of metabolic disorders such as diabetes |
10/08/2013 | US8552061 Locally active “soft” antiandrogens |
10/08/2013 | US8552060 Methods for treatment of sexual dysfunction |
10/08/2013 | US8552059 Treatment of ischemic episodes and cerebroprotection through misoprostol |
10/08/2013 | US8552058 Application of L-n-butylphthalide in preventing and treating dementia |
10/08/2013 | US8552057 Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases |
10/08/2013 | US8552056 Biologically active taxane analogs and methods of treatment by oral administration |
10/08/2013 | US8552055 Dietary and pharmaceutical compositions containing tricyclic diterpenes and their derivates and their uses |
10/08/2013 | US8552054 Anticancer agents, viricides, psychological disorders |
10/08/2013 | US8552053 7-substituted indirubin-3′oximes and their applications |
10/08/2013 | US8552052 Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associated conditions |
10/08/2013 | US8552051 Use of pharmaceutical compositions containing mesembrenone |
10/08/2013 | US8552050 Activators of pyruvate kinase M2 and methods of treating disease |
10/08/2013 | US8552049 Pyrazolecarboxamide derivatives and their use as microbiocides |
10/08/2013 | US8552048 Phosphoramidate alkylator prodrugs for the treatment of cancer |
10/08/2013 | US8552047 Hepatitis C virus inhibitors |
10/08/2013 | US8552046 Manufacture, compositions and uses of coagulation factor VIIa modulator |
10/08/2013 | US8552045 Tricyclic imidazole compounds as PDE10 inhibitors |
10/08/2013 | US8552044 Coatings for disease control |
10/08/2013 | US8552043 N[S(4-aryl-triazol-3-yl)α-mercaptoacetyl]-p-amino benzoic acids as HIV reverse transcriptase inhibitors |
10/08/2013 | US8552042 Use of combination preparations comprising antifungal agents |
10/08/2013 | US8552041 Therapeutic approaches for treating alzheimer disease and related disorders through a modulation of cell stress response |
10/08/2013 | US8552040 Isoxazoline compounds having MIF antagonist activity |
10/08/2013 | US8552039 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide |
10/08/2013 | US8552038 Crystalline forms of thiazolidinedione compound and its manufacturing method |
10/08/2013 | US8552037 Tricyclic compound and pharmaceutical use thereof |
10/08/2013 | US8552036 Polymorph of atazanavir sulfate |
10/08/2013 | US8552035 Phenanthrenone compounds, compositions and methods |
10/08/2013 | US8552034 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof |
10/08/2013 | US8552033 Inhibitors of CXCR2 |
10/08/2013 | US8552032 Bicyclic derivatives useful as inhibitors of DPP-1 |
10/08/2013 | US8552031 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators |
10/08/2013 | US8552030 Process for the preparation of d-threo-ritalinic acid hydrochloride by resolution of dl-threo-ritalinic acid using chiral carboxylic acid |
10/08/2013 | US8552029 Quinoline derivatives and uses of the same |
10/08/2013 | US8552028 8-phenylisoquinolines and pharmaceutical composition used in treatment for sepsis |
10/08/2013 | US8552027 Luminescent compounds |
10/08/2013 | US8552026 Isatin derivatives, medicaments containing the isatin derivatives and method for its preparation |
10/08/2013 | US8552025 Stable methylnaltrexone preparation |
10/08/2013 | US8552024 Azacyclic compounds |
10/08/2013 | US8552023 Non-amidic linkers with branched termini as CGRP receptor antagonists |
10/08/2013 | US8552022 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
10/08/2013 | US8552021 Phosphoramidate derivatives of nucleosides |
10/08/2013 | US8552019 Inhibitors of phosphoinositide dependent kinase 1 (PDK1) |
10/08/2013 | US8552018 Substituted tricyclic compounds as protein kinase inhibitors |
10/08/2013 | US8552017 2-amino-3-sulphonyl-tetrahydro-pyrazolo[1,5-A]pyrido-pyrimidine antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof |
10/08/2013 | US8552016 Anti-cancer cyclopenta(g)quinazoline compounds |
10/08/2013 | US8552015 Quinazolinone derivatives and their use as CB agonists |
10/08/2013 | US8552014 Methods of using selective chemotherapeutic agents for targeting tumor cells |
10/08/2013 | US8552013 Heterocyclic compounds based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
10/08/2013 | US8552011 6-(C2-6alkylseleno)purines and methods for treating neural measles viral infection therewith |
10/08/2013 | US8552010 Inhibitors of Bruton'S tyrosine kinase |
10/08/2013 | US8552009 Substituted pyrimido 4.5-d pyrimidin-4-one compounds for modulating TRPV3 function |
10/08/2013 | US8552008 Deuterated 3-(dihydro-1H-pyrazolo[4,3-D]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use |
10/08/2013 | US8552006 Modulators of cystic fibrosis transmembrane conductance regulator |
10/08/2013 | US8552005 (EN) 3-sulfonyl-pyrazolo[1,5-a] pyrimidines / antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof |